However, we found higher levels of hepatic ATG7 mRNA and ATG7 protein expression in the NASH cohort than in non-NASH patients (Figure 3C,D, respectively). The gene discussed is ATG7; the disease is metabolic dysfunction-associated steatohepatitis.